Emerging role of long non-coding RNAs in cancer precision medicine.

Published in: Molecular & cellular oncology (2019)

A vast majority of the human genome encodes long non-coding RNAs (lncRNAs) as compared to protein-coding genes (PCGs). But most efforts to determine biomarkers of anticancer drug response have focused entirely on PCGs. Comprehensive investigation of lncRNAs and drug response demonstrates that lncRNAs are indeed crucial biomarkers of drug response.

Keyphrases

long non coding rna
poor prognosis
genome wide identification
adverse drug
squamous cell carcinoma
drug induced
emergency department
young adults
amino acid
protein protein